Meeder Asset Management Inc Catalyst Pharmaceuticals, Inc. Transaction History

Meeder Asset Management Inc

$1.48 Billion
Q3 2024

A detailed history of Meeder Asset Management Inc transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Meeder Asset Management Inc holds 4,497 shares of CPRX stock, worth $96,505. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,497

Previous 4,497 -0.0%

Holding current value

$96,505

Previous $69,000 28.99%

% of portfolio

0.01%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$14.68 - $16.92 $66,015 - $76,089	4,497 New	4,497 $69,000
Q4 2022 Feb 14, 2023	SELL	$12.25 - $19.5 $918 - $1,462	-75 Reduced 77.32%	22 $0
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $684 - $1,505	97 New	97 $1,000
Q4 2021 Feb 11, 2022	SELL	$5.21 - $7.45 $96,807 - $138,428	-18,581 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$3.45 - $4.69 $64,104 - $87,144	18,581 New	18,581 $85,000
Q4 2020 Feb 09, 2021	SELL	$2.97 - $3.83 $55,188 - $71,169	-18,582 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$3.48 - $5.05 $16,825 - $24,416	4,835 Added 35.17%	18,582 $86,000
Q1 2020 May 15, 2020	BUY	$2.61 - $5.21 $18,935 - $37,798	7,255 Added 111.75%	13,747 $52,000
Q4 2019 Feb 13, 2020	BUY	$3.67 - $5.7 $11,377 - $17,670	3,100 Added 91.39%	6,492 $25,000
Q3 2019 Oct 17, 2019	SELL	$3.89 - $7.43 $38,351 - $73,252	-9,859 Reduced 74.4%	3,392 $19,000
Q2 2019 Aug 05, 2019	BUY	$2.7 - $6.11 $31,179 - $70,558	11,548 Added 678.1%	13,251 $50,000
Q1 2019 Apr 16, 2019	SELL	$2.11 - $5.33 $68,646 - $173,406	-32,534 Reduced 95.03%	1,703 $9,000
Q4 2018 Jan 17, 2019	BUY	$1.92 - $3.62 $42,675 - $80,461	22,227 Added 185.07%	34,237 $67,000
Q3 2018 Nov 02, 2018	SELL	$2.81 - $3.78 $12,650 - $17,017	-4,502 Reduced 27.27%	12,010 $0
Q2 2018 Jul 24, 2018	BUY	$2.26 - $3.84 $32,091 - $54,528	14,200 Added 614.19%	16,512 $0
Q1 2018 May 03, 2018	BUY	$2.39 - $4.01 $3,073 - $5,156	1,286 Added 125.34%	2,312 $5,000
Q4 2017 Feb 02, 2018	BUY	$2.51 - $4.4 $2,575 - $4,514	1,026	1,026 $3,000

Others Institutions Holding CPRX

# of Institutions

326

Shares Held

94M

Call Options Held

19.1K

Put Options Held

51.1K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.21B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account

Meeder Asset Management Inc Catalyst Pharmaceuticals, Inc. Transaction History